Andrew S. Brohl
Moffitt Cancer Center(US)
Publications by Year
Research Areas
Sarcoma Diagnosis and Treatment, Polyomavirus and related diseases, Immunotherapy and Immune Responses, CAR-T cell therapy research, Bacteriophages and microbial interactions
Most-Cited Works
- → Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors(2014)771 cited
- → The Genomic Landscape of the Ewing Sarcoma Family of Tumors Reveals Recurrent STAG2 Mutation(2014)447 cited
- → Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy(2019)386 cited
- → Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma(2017)386 cited
- → Monogenic and polygenic determinants of sarcoma risk: an international genetic study(2016)210 cited
- → Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial(2020)194 cited
- → Treatment pathway of bone sarcoma in children, adolescents, and young adults(2017)177 cited
- → The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy(2019)166 cited
- → The genomic landscape of malignant peripheral nerve sheath tumors: diverse drivers of Ras pathway activation(2017)148 cited
- → Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma(2021)140 cited